AVNS
AVANOS MEDICAL, INC.
$24.96
-0.08%
$1.2B
No data for this timeframe.
Vol
Market Cap$1.2B
Cap SizeSmall Cap
Inst. Holders50 funds
Inst. Value$327.2M
Inst. Activity10 buys / 8 sells
SEC Reports5
Exchange NYSE·Sector Orthopedic, Prosthetic & Surgical Appliances & Supplies·Inc. DE·CIK 0001606498·Prev Close $24.98
Recent Activity
Jun 10, 2026
SEC
Avanos Medical enters a definitive agreement to be acquired by American Industrial Partners (AIP) for $25.00 per share i
DEFM14A — Impact 8/10
May 27, 2026
Event
HSR Early Termination: AIPCF VIII Indirect Investor AIV LP; Avanos Medical, Inc.
The FTC granted early termination of the HSR Act waiting period for a transaction involving AIPCF VI
May 8, 2026
Insider
Shimer Julie Ann was granted 12,003 shares
Director
May 8, 2026
Insider
OLEARY PATRICK J was granted 12,003 shares
Director
May 8, 2026
Insider
Franchini Indrani Lall was granted 12,003 shares
Director
May 7, 2026
short_volume
Short Volume: AVNS — 67.3% short (0.6M / 0.9M)
Short: 614,991 | Exempt: 22 | TRF Vol: 914,396 | Short Ratio: 67.3% | Off-exchange volume (dark pool
May 5, 2026
SEC
Avanos Medical filed additional definitive proxy soliciting materials (DEFA14A) related to its pending $1.27B acquisitio
DEFA14A — Impact 5/10
Apr 23, 2026
SEC
Avanos Medical is soliciting shareholder approval for its acquisition by A-AV Holdco I, Inc., an entity affiliated with
DEFA14A — Impact 8/10
Analyst Ratings
0Strong Buy
0Buy
3Hold
1Sell
2Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 7, 2024 | JMP Securities | REITERATE | Market Perform |
| Jul 25, 2023 | Keybanc | DOWNGRADE | Overweight → Sector Weight |
| Jun 21, 2023 | Stifel | REITERATE | Hold → Hold |
| May 22, 2023 | CL King | INITIATE | Buy |
| May 4, 2023 | Morgan Stanley | MAINTAIN | Underweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.16 | $0.16 — $0.16 | -6% YoY | 1 |
| Next Q | $0.33 | $0.33 — $0.33 | 50% YoY | 1 |
| Current FY | $1.00 | $1.00 — $1.00 | 6% YoY | 1 |
| Next FY | $1.25 | $1.25 — $1.25 | 25% YoY | 1 |
Latest Reports
BULLISH
DEFM14A
8/10
Avanos Medical enters a definitive agreement to be acquired by American Industrial Partners (AIP) for $25.00 per share i
Jun 10, 2026
NEUTRAL
DEFA14A
5/10
Avanos Medical filed additional definitive proxy soliciting materials (DEFA14A) related to its pending $1.27B acquisitio
May 5, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $95.9M | — |
| DIMENSIONAL FUND ADVISORS LP | $28.8M | — |
| STATE STREET CORP | $27.6M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $27.6M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $17.4M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 8, 2026 | Shimer Julie | A | $0.00 |
| May 8, 2026 | OLEARY PATRICK | A | $0.00 |
| May 8, 2026 | Franchini Indrani | A | $0.00 |
| May 8, 2026 | Egbuonu-Davis Lisa | A | $0.00 |
| May 8, 2026 | BLACKFORD GARY | A | $0.00 |
50 institutional holders with $327.2M total value (23,362,211 shares) as of 2026-Q1. Top holders: BlackRock,, DIMENSIONAL, STATE. Net buying activity: 10 institutions added/increased vs 8 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6,843,733 | $95.9M | 29.3% | — |
| 2 | DIMENSIONAL FUND ADVISORS LP | 2,052,356 | $28.8M | 8.8% | — |
| 3 | STATE STREET CORP | 1,972,523 | $27.6M | 8.4% | — |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1,971,965 | $27.6M | 8.4% | — |
| 5 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1,239,295 | $17.4M | 5.3% | — |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,058,066 | $14.8M | 4.5% | ADD +30.0% |
| 7 | MORGAN STANLEY | 827,662 | $11.6M | 3.5% | ADD +31.4% |
| 8 | D. E. Shaw & Co., Inc. | 671,413 | $9.4M | 2.9% | — |
| 9 | AMERIPRISE FINANCIAL INC | 584,277 | $8.2M | 2.5% | DOUBLED +356.6% |
| 10 | DIAMOND HILL CAPITAL MANAGEMENT INC | 573,940 | $8.0M | 2.5% | ADD +26.0% |
| 11 | ROYCE & ASSOCIATES LP | 513,703 | $7.2M | 2.2% | DOUBLED +746.3% |
| 12 | GOLDMAN SACHS GROUP INC | 480,886 | $6.7M | 2.1% | — |
| 13 | CITADEL ADVISORS LLC | 475,196 | $6.7M | 2.0% | DOUBLED +194.8% |
| 14 | ExodusPoint Capital Management, LP | 421,504 | $5.9M | 1.8% | TRIM -28.1% |
| 15 | FMR LLC | 380,561 | $5.3M | 1.6% | ADD +34.9% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 302,531 | $4.2M | 1.3% | — |
| 17 | LAZARD ASSET MANAGEMENT LLC | 282,642 | $4.0M | 1.2% | — |
| 18 | Trexquant Investment LP | 277,535 | $3.9M | 1.2% | DOUBLED +850.9% |
| 19 | Allianz Asset Management GmbH | 265,572 | $3.7M | 1.1% | ADD +87.9% |
| 20 | Invesco Ltd. | 211,054 | $3.0M | 0.9% | TRIM -31.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | DOUBLED | 60,703 | 513,703 | +746.3% | $7.2M | 2026-Q1 |
| ExodusPoint Capital Management, LP | TRIM | 586,485 | 421,504 | -28.1% | $5.9M | 2026-Q1 |
| Trexquant Investment LP | DOUBLED | 29,186 | 277,535 | +850.9% | $3.9M | 2026-Q1 |
| Allianz Asset Management GmbH | ADD | 141,369 | 265,572 | +87.9% | $3.7M | 2026-Q1 |
| FRANKLIN RESOURCES INC | DOUBLED | 75,816 | 188,953 | +149.2% | $2.6M | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 75,873 | 167,936 | +121.3% | $2.4M | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 85,211 | 110,978 | +30.2% | $1.6M | 2026-Q1 |
| DEUTSCHE BANK AG\ | TRIM | 267,734 | 84,968 | -68.3% | $1.2M | 2026-Q1 |
| Russell Investments Group, Ltd. | TRIM | 111,702 | 79,233 | -29.1% | $1.1M | 2026-Q1 |
| PRUDENTIAL FINANCIAL INC | TRIM | 88,214 | 49,714 | -43.6% | $696.5K | 2026-Q1 |
| FEDERATED HERMES, INC. | ADD | 25,774 | 33,650 | +30.6% | $471.4K | 2026-Q1 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | ADD | 19,367 | 24,752 | +27.8% | $345.3K | 2026-Q1 |
| State of Tennessee, Department of Treasury | TRIM | 41,405 | 22,470 | -45.7% | $314.8K | 2026-Q1 |
| Vident Advisory, LLC | TRIM | 52,049 | 16,687 | -67.9% | $233.8K | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 222 | 11,722 | +5180.2% | $164.2K | 2026-Q1 |
| BNP Paribas Asset Management Holding S.A. | ADD | 1,175 | 1,665 | +41.7% | $23.3K | 2026-Q1 |
| HRT FINANCIAL LP | TRIM | 162,473 | 103,663 | -36.2% | $1.5K | 2026-Q1 |
| Rockefeller Capital Management L.P. | TRIM | 40 | 27 | -32.5% | $378.00 | 2026-Q1 |
| MORGAN STANLEY | ADD | 832,497 | 1,094,036 | +31.4% | $12.3M | 2025-Q4 |
| ExodusPoint Capital Management, LP | ADD | 364,193 | 586,485 | +61.0% | $6.6M | 2025-Q4 |
| FMR LLC | ADD | 271,017 | 365,545 | +34.9% | $4.1M | 2025-Q4 |
| Invesco Ltd. | TRIM | 323,821 | 223,252 | -31.1% | $2.5M | 2025-Q4 |
| Allianz Asset Management GmbH | DOUBLED | 59,535 | 141,369 | +137.5% | $1.6M | 2025-Q4 |
| RHUMBLINE ADVISERS | TRIM | 187,251 | 133,927 | -28.5% | $1.5M | 2025-Q4 |
| Russell Investments Group, Ltd. | ADD | 88,904 | 111,702 | +25.6% | $1.3M | 2025-Q4 |
9 unique insiders with 33 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 8, 2026 | Shimer Julie Ann | Director | AWARD | 12,003 | — | — |
| May 8, 2026 | OLEARY PATRICK J | Director | AWARD | 12,003 | — | — |
| May 8, 2026 | Franchini Indrani Lall | Director | AWARD | 12,003 | — | — |
| May 8, 2026 | Egbuonu-Davis Lisa | Director | AWARD | 12,003 | — | — |
| May 8, 2026 | BLACKFORD GARY | Director | AWARD | 12,003 | — | — |
| Apr 22, 2026 | Delgado Sigfrido | SVP, Operations | TAX W/H | 4,264 | $24.64 | $105.1K |
| Apr 22, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | TAX W/H | 4,228 | $24.64 | $104.2K |
| Apr 14, 2026 | Pacitti David | Chief Executive Officer | TAX W/H | 21,194 | $14.53 | $307.9K |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 15,886 | — | — |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 37,782 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 101,341 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 239,354 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 29,481 | — | — |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 37,520 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 29,481 | — | — |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 15,886 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 239,354 | — | — |
| Mar 13, 2026 | Hurley John Joseph | Principal Accounting Officer | AWARD | 2,211 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 101,341 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 69,630 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 70,115 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 101,341 | — | — |
| Mar 13, 2026 | Pacitti David | Chief Executive Officer | AWARD | 241,021 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 29,481 | — | — |
| Mar 13, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | AWARD | 69,630 | — | — |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 15,886 | — | — |
| Mar 13, 2026 | Delgado Sigfrido | SVP, Operations | AWARD | 37,520 | — | — |
| Mar 9, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | TAX W/H | 1,119 | $13.29 | $14.9K |
| Mar 9, 2026 | Hurley John Joseph | Principal Accounting Officer | TAX W/H | 226 | $13.29 | $3.0K |
| Mar 6, 2026 | Hurley John Joseph | Principal Accounting Officer | TAX W/H | 321 | $13.79 | $4.4K |
| Mar 6, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | TAX W/H | 2,356 | $13.79 | $32.5K |
| Mar 6, 2026 | Galovan Scott Michael | SVP, Chief Financial Officer | EXERCISE | 5,907 | $13.79 | $81.5K |
| Mar 6, 2026 | Hurley John Joseph | Principal Accounting Officer | EXERCISE | 919 | $13.79 | $12.7K |
5 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 6.0/10.
BULLISH
DEFM14A
8/10
Avanos Medical enters a definitive agreement to be acquired by American Industrial Partners (AIP) fo
Jun 10, 2026
NEUTRAL
DEFA14A
5/10
Avanos Medical filed additional definitive proxy soliciting materials (DEFA14A) related to its pendi
May 5, 2026
BULLISH
DEFA14A
8/10
Avanos Medical is soliciting shareholder approval for its acquisition by A-AV Holdco I, Inc., an ent
Apr 23, 2026
NEUTRAL
DEFA14A
4/10
Avanos Medical has postponed its 2026 Annual Meeting of Stockholders, originally set for April 21, 2
Apr 14, 2026
NEUTRAL
8-K
5/10
Avanos Medical has entered into an agreement with activist investor Bradley L. Radoff to add two new
Feb 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action May 2024): 0% buy across 6 analysts — 0 strong buy, 0 buy, 3 hold, 1 sell, 2 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.16 | $0.16 | $0.16 | -5.9% | +0.0% | 0↑ 1↓ | $0.2B | -1.1% | 1 |
| Next Q 2026-09-30 |
$0.33 | $0.33 | $0.33 | 50.0% | +0.0% | 1↑ 0↓ | $0.2B | 1.8% | 1 |
| Current FY 2026-12-31 |
$1.00 | $1.00 | $1.00 | 6.4% | +0.0% | 1↑ 0↓ | $0.7B | 1.3% | 1 |
| Next FY 2027-12-31 |
$1.25 | $1.25 | $1.25 | 25.0% | +0.0% | 0↑ 1↓ | $0.7B | 4.2% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.160 | |
| 7d ago | $0.160 | |
| 30d ago | $0.160 | |
| 60d ago | $0.220 | -0.060 |
| 90d ago | $0.240 | -0.080 |
9 analyst firms have rated this stock: 2 upgrades, 5 downgrades, 2 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 7, 2024 | JMP Securities | REITERATE | — | Market Perform |
| Jul 25, 2023 | Keybanc | DOWNGRADE | Overweight | Sector Weight |
| Jun 21, 2023 | Stifel | REITERATE | Hold | Hold |
| May 22, 2023 | CL King | INITIATE | — | Buy |
| May 4, 2023 | Morgan Stanley | MAINTAIN | — | Underweight |
| Feb 22, 2023 | Morgan Stanley | MAINTAIN | — | Underweight |
| Jan 6, 2023 | Morgan Stanley | MAINTAIN | — | Underweight |
| Nov 3, 2022 | Keybanc | MAINTAIN | — | Overweight |
| Oct 11, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Aug 10, 2022 | Keybanc | MAINTAIN | — | Overweight |
| Jul 18, 2022 | Stifel | MAINTAIN | — | Hold |
| Jul 15, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| May 5, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Feb 24, 2022 | Keybanc | MAINTAIN | — | Overweight |
| Jan 7, 2022 | Morgan Stanley | MAINTAIN | — | Underweight |
| Aug 4, 2021 | Morgan Stanley | MAINTAIN | — | Underweight |
| Aug 4, 2021 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Aug 4, 2021 | Keybanc | MAINTAIN | — | Overweight |
| Jan 8, 2021 | KeyBanc | MAINTAIN | — | Overweight |
| Dec 15, 2020 | Morgan Stanley | MAINTAIN | — | Underweight |
| Nov 4, 2020 | Morgan Stanley | MAINTAIN | — | Underweight |
| Nov 4, 2020 | Keybanc | MAINTAIN | — | Overweight |
| Aug 5, 2020 | Keybanc | MAINTAIN | — | Overweight |
| May 7, 2020 | Morgan Stanley | MAINTAIN | — | Underweight |
| Apr 27, 2020 | Keybanc | MAINTAIN | — | Overweight |
| Apr 13, 2020 | Barclays | UPGRADE | Underweight | Equal-Weight |
| Apr 1, 2020 | Stifel | MAINTAIN | — | Hold |
| Mar 27, 2020 | Morgan Stanley | MAINTAIN | — | Underweight |
| Mar 23, 2020 | Stephens & Co. | MAINTAIN | — | Overweight |
| Dec 17, 2019 | Morgan Stanley | MAINTAIN | — | Underweight |
| Nov 7, 2019 | Stifel | DOWNGRADE | Buy | Hold |
| Nov 6, 2019 | Raymond James | DOWNGRADE | Outperform | Market Perform |
| Nov 6, 2019 | Keybanc | MAINTAIN | — | Overweight |
| Aug 7, 2019 | Raymond James | MAINTAIN | — | Outperform |
| Feb 27, 2019 | Keybanc | MAINTAIN | Overweight | Overweight |
| Jan 4, 2019 | Barclays | DOWNGRADE | Equal-Weight | Underweight |
| Dec 18, 2018 | Keybanc | MAINTAIN | Overweight | Overweight |
| Oct 16, 2018 | Barclays | INITIATE | — | Equal-Weight |
| Oct 11, 2018 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Aug 21, 2018 | Raymond James | UPGRADE | Market Perform | Outperform |
| Aug 8, 2018 | Morgan Stanley | MAINTAIN | Underweight | Underweight |
| Aug 8, 2018 | Keybanc | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| May 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Apr 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Mar 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Feb 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% | |
| Jan 1, 2026 | 0 | 0 | 3 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 27, 2026
Enforcement
HSR Early Termination: AIPCF VIII Indirect Investor AIV LP; Avanos Medical, Inc.
The FTC granted early termination of the HSR Act waiting period for a transaction involving AIPCF VIII Indirect Investor AIV LP; Avanos Medical, Inc..
May 7, 2026
short_volume
Short Volume: AVNS — 67.3% short (0.6M / 0.9M)
Short: 614,991 | Exempt: 22 | TRF Vol: 914,396 | Short Ratio: 67.3% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: AVNS — 69.6% short (0.9M / 1.3M)
Short: 879,892 | Exempt: 0 | TRF Vol: 1,264,678 | Short Ratio: 69.6% | Off-exchange volume (dark pool + OTC)
May 4, 2026
earnings_calendar
AVNS Q1 2026 Earnings Scheduled — 2026-05-04
Feb 24, 2026
earnings_calendar
AVNS Q4 2025 Earnings Before Market Open — 2026-02-24